Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)

Autor: Fineberg, Naomi A., Hollander, Eric, Grant, Jon E., Chamberlain, Samuel R., Drummond, Lynne M., Pellegrini, Luca, Laws, Keith R., Wellsted, David, Reid, Jemma, Nezgovorova, Vera, Baldwin, David S.
Zdroj: In Comprehensive Psychiatry July 2022 116
Databáze: ScienceDirect
Externí odkaz: